Select Medical (SEM)
(Real Time Quote from BATS)
$30.12 USD
+0.67 (2.28%)
Updated Mar 28, 2024 11:42 AM ET
4-Sell of 5 4
A Value B Growth A Momentum A VGM
Income Statements
Fiscal Year end for Select Medical Holdings Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 6,664 | 6,334 | 6,205 | 5,532 | 5,454 |
Cost Of Goods | 5,732 | 5,600 | 5,285 | 4,710 | 4,641 |
Gross Profit | 932 | 733 | 919 | 821 | 813 |
Selling & Adminstrative & Depr. & Amort Expenses | 377 | 330 | 206 | 254 | 341 |
Income After Depreciation & Amortization | 555 | 403 | 714 | 568 | 472 |
Non-Operating Income | 26 | 26 | 52 | 42 | -7 |
Interest Expense | 199 | 169 | 136 | 153 | 201 |
Pretax Income | 382 | 261 | 630 | 456 | 265 |
Income Taxes | 83 | 63 | 130 | 112 | 64 |
Minority Interest | 56 | 39 | 98 | 86 | 53 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 300 | 198 | 500 | 345 | 201 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 243 | 159 | 402 | 259 | 148 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 766 | 611 | 919 | 775 | 696 |
Depreciation & Amortization (Cash Flow) | 211 | 208 | 205 | 208 | 224 |
Income After Depreciation & Amortization | 555 | 403 | 714 | 568 | 472 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 123.11 | 124.70 | 134.98 | 129.78 | 134.95 |
Diluted EPS Before Non-Recurring Items | 1.99 | 1.23 | 2.98 | 1.89 | 1.24 |
Diluted Net EPS (GAAP) | 1.91 | 1.23 | 2.98 | 1.93 | 1.10 |
Fiscal Year end for Select Medical Holdings Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 | |
---|---|---|---|---|---|
Sales | 1,658.86 | 1,665.69 | 1,674.53 | 1,664.98 | 1,581.46 |
Cost Of Goods | 1,447.09 | 1,442.51 | 1,423.60 | 1,418.82 | 1,408.78 |
Gross Profit | 211.77 | 223.18 | 250.92 | 246.16 | 172.67 |
SG&A, R&D, and Dept/Amort Expenses | 97.51 | 93.22 | 91.72 | 94.71 | 85.81 |
Income After SG&A, R&D, and Dept/Amort Expenses | 114.26 | 129.96 | 159.20 | 151.45 | 86.86 |
Non-Operating Income | 10.20 | -3.13 | 10.50 | 8.56 | 6.76 |
Interest Expense | 50.80 | 50.27 | 49.00 | 48.57 | 47.34 |
Pretax Income | 73.65 | 76.56 | 120.71 | 111.44 | 46.28 |
Income Taxes | 11.85 | 15.74 | 28.85 | 26.19 | 8.57 |
Minority Interest | 15.53 | 12.64 | 13.62 | 14.45 | 10.21 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 61.80 | 60.82 | 91.86 | 85.26 | 37.71 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 46.27 | 48.18 | 78.24 | 70.81 | 27.50 |
Earnings Per Share Data | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 |
---|---|---|---|---|---|
Average Shares | 123.82 | 123.40 | 128.26 | 122.55 | 120.46 |
Diluted EPS Before Non-Recurring Items | 0.36 | 0.46 | 0.61 | 0.56 | 0.22 |
Diluted Net EPS (GAAP) | 0.36 | 0.38 | 0.61 | 0.56 | 0.22 |